Y-Intercept (Hong Kong) Ltd

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1772875 HONG KONG, K3

Position in RARE

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$4,574,516

+$2,534,070 QoQ

Shares Held

218,354

+221.9% QoQ

Ownership

0.222%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $167,724,147 across 89 Biotechnology names. RARE ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	35,829	$15,999,081
2	ADMA	Adma Biologics, Inc.	1,075,422	$9,689,552
3	UPB	Upstream Bio, Inc.	1,000,631	$9,005,679
4	ANNX	Annexon, Inc.	1,319,913	$7,312,318
5	XENE	Xenon Pharmaceuticals Inc.	85,388	$4,965,312
6	RARE	Ultragenyx Pharmaceutical Inc. This page	218,354	$4,574,516
7	INCY	Incyte Corp	47,833	$4,502,041
8	BMRN	Biomarin Pharmaceutical Inc	78,338	$4,425,313

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,574,516	218,354	+221.9%	Shares	Sole	2026-04-27
2025-09-30	$2,040,446	67,834	+31.1%	Shares	Sole	2025-10-31
2025-06-30	$1,881,193	51,738	+110.3%	Shares	Sole	2025-08-01
2025-03-31	$890,766	24,600	-7.8%	Shares	Sole	2025-05-06
2024-12-31	$1,123,058	26,695	+39.4%	Shares	Sole	2025-02-04
2024-09-30	$1,063,838	19,151	+193.1%	Shares	Sole	2024-11-15
2024-06-30	$268,547	6,534	-41.3%	Shares	Sole	2024-08-14
2024-03-31	$519,379	11,124	-28.0%	Shares	Sole	2024-05-10
2023-09-30	$550,507	15,442	+415.1%	Shares	Sole	2023-11-14
2021-12-31	$252,101	2,998	-43.4%	Shares	Sole	2022-02-14
2021-06-30	$504,782	5,294	+21.7%	Shares	Sole	2021-08-26
2021-03-31	$495,404	4,351	+37.3%	Shares	Sole	2021-05-12
2020-12-31	$438,684	3,169	—	Shares	Sole	2021-02-05
No filing history on record for this holder in this stock.